Delivery Order SPE2DB22D3016-SPE2DB25FBGH7
Award Date 8/27/25
Potential Completion Date 8/28/25
Potential Value $2.5K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,666.37 firm fixed price delivery order for 1,440 units of HAVRIX 1,440 Unit/mL syringe on April 18, 2025, with ultimate completion scheduled for April 21, 2025. This non-set-aside contract was competitively awarded to AmerisourceBergen's Corporate Office, with performance to occur at the company's Conshohocken, Pennsylvania headquarters. HAVRIX is a hepatitis A vaccine commonly utilized by the Department of Defense for...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on August 19, 2025, with ultimate completion by August 20, 2025. This is a firm fixed price delivery order with no set-aside designation, performed at the vendor's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used across military and federal healthcare systems for disease prevention and immunization...
- The Defense Logistics Agency awarded a delivery order valued at $2,991.25 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes on August 7, 2025, with completion targeted for August 8, 2025. This firm fixed-price delivery order represents a competitively awarded, non-set-aside contract with performance taking place at the contractor's Corporate Office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare settings to...
- The Defense Logistics Agency awarded a $2,408.49 delivery order to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 mL syringes, with an ultimate completion date of September 29, 2025. This non-set-aside contract award reflects a firm fixed-price delivery order executed on September 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare systems to support troop readiness and...
- The Defense Logistics Agency awarded a delivery order valued at $10,140.60 to AmerisourceBergen Drug Corp for 1,440 units/milliliter of HAVRIX vaccine delivered via syringe. This firm fixed price, non-set-aside contract was awarded on July 15, 2025, with an ultimate completion date of July 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine used to support immunization requirements across the Department...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp on January 13, 2025, for the supply of HAVRIX 720 Unit/0.5 ML syringes. This firm fixed-price, non-set-aside contract will be completed by January 14, 2025, with performance taking place at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used in military and federal healthcare settings, and this delivery order represents a routine...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,012.20 to AmerisourceBergen Drug Corp for HAVRIX 720 Unit/0.5 ML syringes on July 29, 2025, with an ultimate completion date of July 30, 2025. This competitively awarded, firm fixed-price contract involves no set-aside designation and will be performed at the awardee's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine product, reflecting the ongoing federal medical procurement needs for...
- The Defense Logistics Agency awarded a delivery order valued at $11,651.70 to AmerisourceBergen Drug Corp for the supply of HAVRIX 720 Unit/0.5 ML syringes, with an ultimate completion date of September 15, 2025. This firm fixed-price contract, awarded on September 12, 2025, represents a non-competitive set-aside delivery and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly utilized across military and federal...
- The Defense Logistics Agency awarded a delivery order valued at $2,024.40 to AmerisourceBergen Drug Corp for the supply of HAVRIX 720 Unit/0.5 mL syringes on September 26, 2025, with completion scheduled for September 29, 2025. This firm fixed price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. HAVRIX is a hepatitis A vaccine commonly used by the Department of Defense for military personnel...
- The Defense Logistics Agency awarded a $22,225.50 delivery order to AmerisourceBergen Drug Corp for 1,440 units of Havrix 1-mL syringes on June 6, 2025, with a completion date of June 9, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. Havrix is a hepatitis A vaccine commonly used in military and federal healthcare systems to maintain immunization...